HAE News and Press, Haemonetics Corporation From 05/08/25

Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website PR Newswire Financial release accessible online BOSTON , May 8, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financia...

2025-05-07 18:48:21 ET Haemonetics Corporation (HAE) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 3.48%. The average open to low on the day of earnings was -4.43%. The average open to...

2025-05-07 18:43:22 ET Haemonetics Corporation (HAE) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in HAE stock price following earnings has averaged ±4.63% , with a median of 4.83%. ...

2025-05-07 12:00:03 ET More on Haemonetics Haemonetics: Almost Blood In The Streets Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript Haemonetics downgraded at Bank of America on revised FY25 outlook Haemonetics' stock slides on revenue miss ...

2025-05-06 00:39:00 ET Summary Small-caps remain much more attractively valued than large-caps and opportunities are plentiful. The Fund’s top five contributors in 1Q25 are longer-term holdings in which we have high conviction. We remain confident in the long-term prosp...

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 PR Newswire BOSTON , March 31, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2025...

2025-03-27 22:35:00 ET Summary Royce Small-Cap Fund declined 1.8% for the quarter, lagging its benchmark, Russell 2000 Index, which was up 0.3% for the same period. Six of the portfolio’s 10 sectors made a negative impact on quarterly performance. We feel very confident...

2025-03-03 16:23:16 ET More on Haemonetics Haemonetics: Almost Blood In The Streets Haemonetics: Reassessing Its Growth Trajectory (Rating Downgrade) Haemonetics downgraded at Bank of America on revised FY25 outlook Haemonetics' stock slides on revenue miss ...

Haemonetics Announces Executive Leadership Updates PR Newswire Frank Chan joins Haemonetics as Executive Vice President, Chief Operating Officer; Roy Galvin named Executive Vice President, Chief Commercial Officer BOSTON , March 3, 2025 ...

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference PR Newswire BOSTON , Feb. 24, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon , President and CEO, will participate in a fireside chat w...